Search
for
Sort by
Research 31–60 of 1000+
- Insulin Resistance, Hyperandrogenism, and Its Associated Symptoms Are the Precipitating Factors for Depression in Women With Polycystic Ovarian Syndrome
- Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making
- Exploring the therapeutic potential of phytochemicals apigenin and ellagic acid in managing polycystic ovarian syndrome and its comorbidities: a comprehensive review
- Hair regeneration: Mechano-activation and related therapeutic approaches.
- Metabolic Syndrome, Cardiovascular Disease and the Hair Growth Cycle: Addressing hair growth disruptions using Nourkrin® with Marilex® as a proteoglycan replacement therapy: A concise review
- Therapeutic approach for metabolic disorders and infertility in women with PCOS
- Therapeutic applications and pharmacoeconomics of microneedle technology
- Exploring The Therapeutic Potential Of Herbal Intervention In Polycystic Ovary Syndrome: A Systemic Review And Meta-Analysis
- Potential role and therapeutic interests of myo-inositol in metabolic diseases
- Update on the therapeutic role of metformin in the management of polycystic ovary syndrome: Effects on pathophysiologic process and fertility outcomes
- In Search of New Therapeutics—Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond
- Metformin or thiazolidinedione therapy in PCOS?
- Green Tea as a Supportive Therapy for PCOS: Evaluating Its Impact on Symptom Relief
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Effect of Metformin Therapy on Clinical and Hormonal Indices of Patients with Polycystic Ovary Syndrome
- A Review of Therapeutic Applications of Nutraceuticals in Polycystic Ovarian Disease
- Biological Investigation of Aqueous Extract of Funnel Seeds to Check its Therapeutic Effects in the Management of Polycystic Ovarian Syndrome in Induced PCOS Female Albino Rats
- IGFBP‐rP1 is a potential therapeutic target in androgenic alopecia
- Chemical Constituents of Halophyte Suaeda glauca and Their Therapeutic Potential for Hair Loss
- Familial Cortisol Resistance: Differential Diagnostic and Therapeutic Aspects
- Cellular senescence and polycystic ovary syndrome: mechanisms and therapeutic strategies from a new perspective
- Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
- Polycystic Ovary Syndrome: Special Diagnostic and Therapeutic Considerations for Children
- Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Metabolic and hormonal effects of a combined Myo-inositol and d-chiro-inositol therapy on patients with polycystic ovary syndrome (PCOS)
- Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease
- LncRNA-miRNA-mRNA regulatory networks in skin aging and therapeutic potentials
- Clinical Utility of GnRH Analogues in Female Androgen Excess: Highlighting Diagnostic and Therapeutic Applications